Hémoptysies chez un jeune homme

Gilbert, Otto; Mathieu, Dominique; Hanquet, O.; Lardinois, Ines; Cornut, P.L.; Pierard, Philippe; Meerhaeghe, Alain Van

doi:10.1016/s0761-8425(06)71820-4

Cited by 7 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…His urine toxicology revealed a significant level of cannabis and a trace of cocaine. 13 Another case of 16 years old male who was hospitalized for hemoptysis expectoration and found to have cannabis use 2 hours before admission, has been described by Monfort et al 14 …”

Section: Discussionmentioning

confidence: 96%

A Case Report of Cannabis Induced Hemoptysis

2016

View full text Add to dashboard Cite

As the principal route of marijuana use is by inhalation, potential harmful consequences on pulmonary structure and function can be anticipated. Here, we present a case of hemoptysis attributed to smoking cannabis in a 38-year-old man. The patient experienced an episode of hemoptysis and shortness of breath immediately after smoking marijuana. Chest radiograph and computed tomography (CT) scans of the chest showed bilateral diffuse ground-glass opacities. A fiber optic bronchoscopy confirmed bilateral diffuse bleeding from respiratory tract. Additional evaluation of hemoptysis indicated no infection or immunological responses. Urine toxicology was positive for cannabis.Chronic marijuana smoking causes visible and microscopic injury to the larger airways responsible for symptoms or chronic bronchitis. We review the beneficial and deleterious effects of marijuana and describe a case of significant hemoptysis attributed to smoking marijuana. In addition to other respiratory complications of marijuana use, physicians should educate their patients about this potentially lethal effect of marijuana smoking in the form of hemoptysis.

show abstract

Section: Discussionmentioning

confidence: 96%

A Case Report of Cannabis Induced Hemoptysis

2016

View full text Add to dashboard Cite

show abstract

“…We observed 10 cases of haemoptysis, probably related to adulterants rather than cannabinoids. Literature reports one case of fatal alveolar haemorrhage in an exclusive cannabis user, and it was attributed to the anhydride acids released during the combustion of artisanal pipe plastics [24]. Inhaled cannabis has been shown to induce a concentration of carboxyhaemoglobin 5-fold greater than Column 1 ('AEs') gives the numbers of all AEs whereas column 2 ('Patients per AE') gives the number of patients who have developed these AEs.…”

Section: Discussionmentioning

confidence: 99%

Cannabis‐related hospitalizations: unexpected serious events identified through hospital databases

Jouanjus

Leymarie

Tubery

et al. 2011

Brit J Clinical Pharma

View full text Add to dashboard Cite

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• The general knowledge on cannabis toxicity has improved, but quantitative data are still lacking.• Little is known about the somatic complications associated with cannabis exposure. Available data rest upon case reports and only a few studies have been conducted in this field.• Psychiatric disorders related to cannabis exposure are somehow still controversial.WHAT THIS STUDY ADDS• Quantitative estimates are key to comprehending the risks of medical outcomes in cannabis users, in particular the somatic complications of use. Our study suggests that cannabis use has to be linked to serious health defects, particularly neurological and cardiovascular disorders.• Our study gives estimates of the annual incidence of cannabis‐related hospitalizations.• Our study should contribute to enhancing the medical management of cannabis using patients.AIMS Cannabis is the most prevalent illicit drug used worldwide and can be responsible for serious health defects in users. However, the risk related to cannabis consumption is not well established. The present study aimed to assess cannabis‐related adverse events leading to hospitalization, and to estimate the corresponding annual risk for consumers.METHODS Participants were patients admitted to the public hospitals in the Toulouse area (France) between January 2004 and December 2007 in relation to the use of cannabis. Reasons for admission and other occurring events were identified through hospital discharge summaries. We described all observed adverse events (AEs) and estimated their regional incidence on the basis of cannabis consumption data.RESULTS We included 200 patients, and identified a total of 619 adverse events (AEs), one of which was lethal. Psychiatric disorders involved 57.7% of patients and accounted for 18.2% of AEs. Most frequent outcomes were central and peripheral nervous system disorders (15.8% of AEs), acute intoxication (12.1%), respiratory system disorders (11.1%) and cardiovascular disorders (9.5%). We estimated that in 2007 the incidence of cannabis‐related AEs in the Midi‐Pyrenees region ranged from 1.2 per 1000 regular cannabis users (95% confidence interval (CI) 0.7, 1.6) to 3.2 (95% CI 2.5, 3.9).CONCLUSIONS Cannabis use is associated with complications, considered to be serious since they lead to hospitalization. Beyond the well‐known and widely investigated psychiatric events, serious cerebro and cardiovascular complications have been identified. These findings contribute to improve the knowledge of cannabis‐related adverse events.

show abstract